The SNPD ETF targets companies with at least 10 years of consecutive dividend growth, blending established Dividend Kings with promising newer payers. Its top holdings include Johnson & Johnson, Procter & Gamble, Coca-Cola, Lowe’s, and PepsiCo, most of which generate strong free cash flow to comfortably cover dividends. While PepsiCo shows some cash flow pressure, the fund’s diversification mitigates risk. SNPD suits investors seeking reliable dividend growth rather than high current yield, delivering steady income with potential for compounding returns.
Johnson & Johnson, McDonald's, and Kinder Morgan stand out as reliable dividend growers heading into late 2026. Johnson & Johnson raised its dividend for the 64th consecutive year, backed by strong revenue and earnings growth driven by oncology produ...
Johnson & Johnson (JNJ) has been upgraded from Hold to Buy due to its consistent performance, stable revenue growth, and defensive qualities. The stock trades at a 20x forward P/E, reflecting a justified premium over peers supported by above-industry...
The 16th annual PODD (Partnership Opportunities in Drug Delivery) conference will take place on October 29-30, 2026, in Boston, gathering over 1,000 industry leaders to discuss advancements in drug delivery systems. The event features over 150 sessio...
Johnson & Johnson is distinguished by its steady growth, deep portfolio, and resilience, setting it apart from AI-driven and other pharma peers. The company’s diversified pharma and MedTech assets support robust revenue growth, with 28 platforms gene...
The global hyperpigmentation treatment market, valued at $1.52 billion in 2025, is projected to grow to $2.85 billion by 2035 at a CAGR of 6.5%. Growth is fueled by rising consumer awareness of skin aesthetics, increasing cases of pigmentation disord...
